Shareholdings of the Board of Directors on 31 December 2025
| Director | A shares | B shares | Total |
| Veli-Matti Mattila, Chair | 460 | 9,639 | 10,099 |
| Hilpi Rautelin, Vice Chair | 4,800 | 5,920 | 10,720 |
| Kari Jussi Aho | 85,263 | 2,806 | 88,069 |
| Maziar Mike Doustdar | 0 | 1,926 | 1,926 |
| Ari Lehtoranta | 0 | 5,614 | 5,614 |
| Eija Ronkainen | 535,500 | 41,056 | 576,556 |
| Henrik Stenqvist | 0 | 2,971 | 2,971 |
| Karen Lykke Sørensen | 0 | 1,926 | 1,926 |
| Board total | 626,023 | 71,858 | 697,881 |
Shareholdings of the Executive Management Board on 31 December 2025
| Member | Position | A shares | B shares on | Total |
| Liisa Hurme | President & CEO | 0 | 51,673 | 51,673 |
| Satu Ahomäki | EVP, Generics and Consumer Health | 0 | 36,549 | 36,549 |
| Juhani Kankaanpää | EVP, Global Operations | 0 | 11,753 | 11,753 |
| Mikko Kemppainen | General Counsel | 0 | 32,416 | 32,416 |
| René Lindell | CFO | 0 | 4,608 | 4,608 |
| Niclas Lindstedt | EVP, Animal Health | 0 | 9,397 | 9,397 |
| Julia Macharey | EVP, People & Culture | 0 | 7,356 | 7,356 |
| Hao Pan | EVP, Branded Products | 0 | 14,913 | 14,913 |
| Outi Vaarala | EVP, Innovative Medicines / Research & Development | 0 | 22,380 | 22,380 |
| Management total | 0 | 191,045 | 191,045 |